Company
Nura Bio
Halting neurological disease in its tracks
- Founded
- 2018
Claim, correct or request removal
Record updated 23 September 2026
About
We seek to alter the course of neurological diseases by targeting fundamental pathways underlying axon degeneration and neuroimmune regulation to preserve neuronal integrity.
Funding snapshot
- Total raised
- $142MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Series B, $73.8M2026-06-22
Funding rounds
- Series B
- $73.8M2026-06-22, Company stated
- Series A
- $68M2024-09-17, Company stated
Products
- Other
- NB-4746
- Web
- NB-4746
Loading relationship preview